These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10509559)

  • 1. The interaction of opportunistic infections and HIV replication.
    Powderly WG
    AIDS; 1999 Sep; 13(13):1603-6. PubMed ID: 10509559
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of hepatitis C virus replication and liver damage in HIV-coinfected patients on antiretroviral combination therapy.
    Vento S; Garofano T; Renzini C; Casali F; Ferraro T; Concia E
    AIDS; 1998 Jan; 12(1):116-7. PubMed ID: 9456265
    [No Abstract]   [Full Text] [Related]  

  • 3. HIV's other immune-system targets: macrophages.
    Balter M
    Science; 1996 Nov; 274(5292):1464-5. PubMed ID: 8966614
    [No Abstract]   [Full Text] [Related]  

  • 4. Exploring the benefits and limits of highly active antiretroviral therapy.
    D'Aquila R; Walker B
    JAMA; 1999 Nov; 282(17):1668-9. PubMed ID: 10553795
    [No Abstract]   [Full Text] [Related]  

  • 5. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load.
    Maurer T; Ponte M; Leslie K
    N Engl J Med; 2007 Sep; 357(13):1352-3. PubMed ID: 17898112
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune restoration with antiretroviral therapies: implications for clinical management.
    Lederman MM; Valdez H
    JAMA; 2000 Jul; 284(2):223-8. PubMed ID: 10889597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of highly active antiretroviral therapy on recurrent oropharyngeal candidiasis in HIV-infected patients.
    Revankar SG; Sanche SE; Dib OP; Caceres M; Patterson TF
    AIDS; 1998 Dec; 12(18):2511-3. PubMed ID: 9875598
    [No Abstract]   [Full Text] [Related]  

  • 8. A killer mimotope with therapeutic activity against AIDS-related opportunistic micro-organisms inhibits ex-vivo HIV-1 replication.
    Casoli C; Pilotti E; Perno CF; Balestra E; Polverini E; Cassone A; Conti S; Magliani W; Polonelli L
    AIDS; 2006 Apr; 20(7):975-80. PubMed ID: 16603848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV and your immune system. How they work and why it's important.
    Cervio JS
    Posit Aware; 2009; 20(5):17-21. PubMed ID: 19785102
    [No Abstract]   [Full Text] [Related]  

  • 10. Presenting plasma HIV RNA level and rate of CD4 T-cell decline.
    Gottlieb GS; Hawes SE; Nickle DC; Herbeck JT; Kiviat NB; Mullins JI; Sow PS
    JAMA; 2007 Feb; 297(8):805; author reply 806-7. PubMed ID: 17327518
    [No Abstract]   [Full Text] [Related]  

  • 11. [Visceral leishmaniasis associated with human immunodeficiency virus infection (reply)].
    Berenguer J; Cosín J; Miralles P; López JC; Padilla B
    Enferm Infecc Microbiol Clin; 2002 Mar; 20(3):133. PubMed ID: 11904089
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360).
    Erice A; Tierney C; Hirsch M; Caliendo AM; Weinberg A; Kendall MA; Polsky B;
    Clin Infect Dis; 2003 Aug; 37(4):567-78. PubMed ID: 12905142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Change in natural history of opportunistic infections in HIV-infected patients.
    Schneider MM
    Neth J Med; 2000 Jul; 57(1):1-3. PubMed ID: 10862994
    [No Abstract]   [Full Text] [Related]  

  • 14. Trends over time of virological and immunological characteristics in the Swiss HIV Cohort Study.
    Ledergerber B; Cavassini M; Battegay M; Bernasconi E; Vernazza P; Hirschel B; Furrer H; Rickenbach M; Weber R;
    HIV Med; 2011 May; 12(5):279-88. PubMed ID: 20955356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-alpha generation and immune reconstitution during antiretroviral therapy for human immunodeficiency virus infection.
    Siegal FP; Fitzgerald-Bocarsly P; Holland BK; Shodell M
    AIDS; 2001 Sep; 15(13):1603-12. PubMed ID: 11546934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pneumocystis carinii pneumonia in HIV-infected patients.
    May TA; Gruta CI; Goldschmidt RH
    Am Fam Physician; 2000 Oct; 62(8):1783, 1786. PubMed ID: 11057837
    [No Abstract]   [Full Text] [Related]  

  • 17. Joint effects of HIV-1 RNA levels and CD4 lymphocyte cells on the risk of specific opportunistic infections.
    Williams PL; Currier JS; Swindells S
    AIDS; 1999 Jun; 13(9):1035-44. PubMed ID: 10397533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sharp drop in the prevalence of human cytomegalovirus leuko-DNAemia in HIV-infected patients following highly active antiretroviral therapy.
    Gerna G; d'Arminio Monforte A; Zavattoni M; Sarasini A; Testa L; Revello MG; Moroni M
    AIDS; 1998 Jan; 12(1):118-20. PubMed ID: 9456267
    [No Abstract]   [Full Text] [Related]  

  • 19. Enhanced in vivo human immunodeficiency virus-1 replication in the lungs of human immunodeficiency virus-infected persons with Pneumocystis carinii pneumonia.
    Koziel H; Kim S; Reardon C; Li X; Garland R; Pinkston P; Kornfeld H
    Am J Respir Crit Care Med; 1999 Dec; 160(6):2048-55. PubMed ID: 10588627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of a cohort of HIV-infected patients who discontinued maintenance therapy for cytomegalovirus retinitis.
    Walmsley SL; Raboud J; Angel JB; Mazzulli T; Shen S; Casciaro L; Young CD; Moussa G; Gough K; Rachlis A; Hopkins J
    HIV Clin Trials; 2006; 7(1):1-9. PubMed ID: 16632459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.